This topic contains a solution. Click here to go to the answer

Author Question: Describe the fundamental flaw that prevents a nonequivalent group design from being a true ... (Read 50 times)

deesands

  • Hero Member
  • *****
  • Posts: 514
Describe the fundamental flaw that prevents a nonequivalent group design from being a true experiment. (That is, why can't these designs produce an unambiguous cause-and-effect explanation?) Explain how the pretest scores in a pretest-posttest nonequivalent control group design help reduce this problem.
 
  What will be an ideal response?

Question 2

What social threat to internal validity occurs when the control group is given a program or treatment (usually by a well-meaning third party) designed to make up for the treatment the program group receives?
 
  a. diffusion of treatment
 b. compensatory rivalry
 c. resentful demoralization
 d. compensatory equalization



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Brenm

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

The basic flaw with a nonequivalent group design is that there is no assurance that the different groups in the study were equivalent before the treatments were administered. As a result, there are always two possible explanations for any differences that may be found between treatments: the differences may be caused by the treatments or the differences may have existed before the treatments were introduced. This problem is reduced by the pretest measurements in a pretest-posttest nonequivalent control group design. If the two groups have similar pretest scores, then you have some assurance that the two groups are equivalent, at least for the variable being measured.

Answer to Question 2

d





 

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

For a complete list of videos, visit our video library